Birchview Capital, LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,837,000
-21.6%
10,672
-42.8%
1.25%
-10.8%
Q2 2021$2,343,000
-7.5%
18,6720.0%1.40%
-6.7%
Q1 2021$2,532,000
+6.0%
18,6720.0%1.50%
+9.2%
Q4 2020$2,389,000
-43.1%
18,672
-50.0%
1.38%
-2.0%
Q3 2020$4,202,000
+136.2%
37,344
+100.0%
1.40%
+30.6%
Q2 2020$1,779,000
+6.0%
18,6720.0%1.08%
-27.8%
Q1 2020$1,678,000
+69.5%
18,6720.0%1.49%
+106.7%
Q4 2019$990,000
+34.1%
18,6720.0%0.72%
+46.3%
Q3 2019$738,000
-3.8%
18,6720.0%0.49%
+5.6%
Q2 2019$767,000
-11.8%
18,6720.0%0.47%
-14.5%
Q1 2019$870,000
+7.0%
18,6720.0%0.54%
-29.1%
Q4 2018$813,000
+18.3%
18,672
+55.6%
0.77%
+73.6%
Q3 2018$687,000
+18.0%
12,0000.0%0.44%
+11.9%
Q2 2018$582,000
-40.5%
12,000
-52.0%
0.40%
-38.5%
Q1 2018$978,000
-7.8%
25,0000.0%0.64%
+3.5%
Q4 2017$1,061,000
+13.7%
25,0000.0%0.62%
+29.0%
Q3 2017$933,000
+104.6%
25,000
+66.7%
0.48%
+100.0%
Q2 2017$456,00015,0000.24%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 938,490$120,070,00033.50%
Foresite Capital Management III, LLC 108,630$13,898,00016.15%
Octagon Capital Advisors LP 112,363$14,376,0004.98%
Artal Group S.A. 1,400,000$179,116,0003.84%
Avoro Capital Advisors LLC 1,550,000$198,307,0003.42%
Affinity Asset Advisors, LLC 45,000$5,757,0003.05%
NWI MANAGEMENT LP 200,000$25,588,0002.54%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 71,000$9,063,0002.48%
FARALLON CAPITAL MANAGEMENT LLC 2,600,000$332,644,0002.00%
Parkman Healthcare Partners LLC 52,458$6,711,0001.72%
View complete list of ACCELERON PHARMA INC shareholders